Signet Ring Cell Carcinoma of Resectable Metastatic Colorectal Cancer Has Rare Surgical Value
Signet Ring Cell Carcinoma of Resectable Metastatic Colorectal Cancer Has Rare Surgical Value
复制标题
DOI:
10.1002/jso.24437
复制
发表时间:
2016-12-15
影响因子:
2.5
通讯作者:
Du, Jinlin
中科院分区:
文献类型:
--
作者:
Fu, Jianfei;Wu, Lunpo;Du, Jinlin
Background and Objectives: Signet ring cell carcinoma (SRCC) is a uniquely separated subgroup in metastatic colorectal cancer (mCRC). The aims are to investigate the value of resection in patients with resectable metastatic signet ring cell colorectal cancer.Methods: Patients with mCRC who underwent resection in Surveillance, Epidemiology, and End Results database during 1998-2010 were retrospectively analyzed. Kaplan-Meier and COX models were used to analyze the differences in the survival. Logistic regression models were used to evaluate the relationship between SRCC and other clinicopathological factors.Results: Among the 3,568 patients, 94 (2.63%) patients had SRCC. The median survival time of patients with SRCC and non-SRCC were 17 and 29 months, respectively (P < 0.001). Multivariate analysis indicated that SRCC was an independent prognostic factor for poor overall survival. Logistic regression model based on variables identified by univariate analysis indicated that younger age (